NCT04712851 2026-03-10
Pembrolizumab for the Treatment of Cervical Intraepithelial Neoplasia
Jonsson Comprehensive Cancer Center
Phase 2 Recruiting
Clinical Trials
5 trialsNCT07454915 2026-03-09
PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia
PapiVax Biotech, Inc.
Phase 2 Not yet recruiting
NCT06519994 2025-12-17
Feasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment in Kenya
UNC Lineberger Comprehensive Cancer Center
Phase 2 Active not recruiting
NCT04098744 2025-10-02
ART-CIN_IIB
Frantz Viral Therapeutics, LLC
Phase 2 Recruiting
NCT03267680 2025-04-13
IRX-2 Regimen in Treating Women With Cervical Squamous Intraepithelial Neoplasia 3 or Squamous Vulvar Intraepithelial Neoplasia 3
University of Southern California
Phase 2 Terminated